RESUMEN
OBJECTIVES: To evaluate the type, frequency, severity and predictors of potential Drug-Drug Interactions (DDIs) in a cohort of patients undergoing radiodiagnostic procedures. SETTING: Eight Radiology wards located in Tuscany (Italy). METHODS: All participants exposed to at least two medications were included in the analysis. DDIs were grouped according to their severity as 'minor', 'moderate' or 'major'. A logistic model was used to estimate Odds Ratios and 95% Confidence Intervals for all predictors of potential DDI. MAIN OUTCOME MEASURES: Type and predictors of potential DDI in a cohort of patients undergoing radiodiagnostic procedures. RESULTS: One-thousand-and-two subjects (57.6% females; mean age: 67.3 +/- 12.2) entered the analysis, and 46.1% of them incurred in a potential DDI (78.9% 'moderate' in severity). The combination of allopurinol and ACE-inhibitors was the most frequent (21/153) among major potential DDIs, while steroids were involved in all cases of potential DDI due to premedication. Co-morbidity, number of co-medications, advanced age and premedication use increased the risk of potential DDI; a protective role was found for positive history of allergy. When the analysis was restricted to subjects with premedication (n = 93), only 12.9% of them reported a potential DDI directly attributable to premedication drugs. CONCLUSIONS: Among patients undergoing radiological examination, types and predictors of potential DDIs appeared in agreement with other kind of in-hospital populations. Premedication revealed to be a proxy predictor for potential DDIs. Considering the poor capability of the prescriber in recognizing interactions, their systematic evaluation (using an informatics tool) in patients undergoing radiological examination might be helpful in preventing the occurrence of clinically relevant DDIs.
Asunto(s)
Interacciones Farmacológicas , Imagen por Resonancia Magnética , Radiografía/métodos , Factores de Edad , Anciano , Estudios de Cohortes , Comorbilidad , Femenino , Administración Hospitalaria , Humanos , Masculino , Persona de Mediana Edad , Polifarmacia , PremedicaciónRESUMEN
We report a case of increase in serum tumour markers CA 125 and CA 19.9 induced by cyclic combined hormone replacement therapy (HRT). A 52-year-old Caucasian post-menopausal woman presented with a slight enlargement of the right ovary and uterine fibromyomatosis. She was taking HRT for 4 years in a cyclic combined regimen of 2 mg oestradiol with 1 mg cyproterone acetate. The serum tumour markers occasionally measured were in normal range except CA 19.9 (997 U/mL; normal values 0.0-37) and CA 125 (85 U/mL; normal values 0.0-35). However, on one occasion, the CA 19.9 and CA 125 were high and then showed persistently high values (1005 and 81.3 U/mL, respectively). Radiodiagnostic investigations excluded any malignancies and a hysteroscopy showed endometrial thickening. After discontinuation of HRT, CA 125 levels returned to normal after 1 month, whereas CA 19.9 took 6 months to do so. Four months after the beginning subsequent therapy with over-the-counter phyto-oestrogens a new serum test showed an increase in CA 19.9 but CA 125 remained within the normal range. Phyto-oestrogen therapy was then interrupted and 1 month later CA 19.9 returned to normal. In this case, cyclic HRT was the probable cause of CA 19.9 and CA 125 increase. Positive dechallenge and subsequent CA 19.9 increase after phyto-oestrogen intake seem to confirm the role of oestrogens as the cause of the endometrial thickening through hormonal imbalance. Increased CA 19.9 and CA 125 levels in benign gynaecological conditions may be a source of misdiagnosis of malignant disease.
Asunto(s)
Antígeno Ca-125/sangre , Antígeno CA-19-9/sangre , Terapia de Reemplazo de Estrógeno/efectos adversos , Biomarcadores de Tumor/sangre , Acetato de Ciproterona/administración & dosificación , Acetato de Ciproterona/efectos adversos , Esquema de Medicación , Combinación de Medicamentos , Estradiol/administración & dosificación , Estradiol/efectos adversos , Femenino , Humanos , Persona de Mediana Edad , Fitoestrógenos/administración & dosificación , Fitoestrógenos/efectos adversos , PosmenopausiaRESUMEN
The aim of this work was to investigate the possible protective effect of a new viscosising agent, TS-polysaccharide, on corneal-derived cells (SIRC) exposed to ultraviolet-B rays. To verify this, SIRC cells were first exposed, in the absence or in the presence of TS-polysaccharide (1% w/v), for 9 s at the UV-B source and then post-incubated for 45 min at 37 degrees C. After this period the hydrogen peroxide (H(2)O(2)) accumulated in the medium and the concentration of 8-hydroxy-2'-deoxy-guanosine (8-OHdG) in cell DNA was measured. In addition, the amount of (3)H-methyl-thymidine incorporated in cellular DNA was evaluated after 18 h from irradiation. Our results show that cells exposed to UV-B rays accumulate H(2)O(2), and have higher levels of 8OHdG and a lower amount of (3)H-methyl-thymidine incorporated in DNA than control cells. In the presence of TS-polysaccharide, the H(2)O(2) and 8-OHdG accumulation, and the (3)H-methyl-thymidine incorporation were significantly reduced with respect to the values measured in cells exposed in the absence of the polysaccharide. We propose a protective role of the polysaccharide in reducing UV-B derived DNA damage to eye cells. This finding could be of some clinical importance when the polysaccharide is used as a delivery system for ophthalmic preparations.
Asunto(s)
Córnea/efectos de los fármacos , Córnea/efectos de la radiación , Desoxiguanosina/análogos & derivados , Polisacáridos/farmacología , Protectores contra Radiación/farmacología , Tamarindus/química , Timidina/análogos & derivados , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Células Cultivadas , Córnea/citología , Medios de Cultivo , ADN/efectos de los fármacos , ADN/efectos de la radiación , Desoxiguanosina/metabolismo , Proteínas del Ojo/metabolismo , Peróxido de Hidrógeno/metabolismo , Oxidación-Reducción , Polisacáridos/aislamiento & purificación , Conejos , Protectores contra Radiación/aislamiento & purificación , Timidina/metabolismo , Rayos UltravioletaRESUMEN
Characterisation of the pharmacological profile of non-physiological amine oxidase substrates could help to identify the endogenous role of this class of enzymes. Previous studies have suggested that benzylamine, a common non-physiological substrate for monoamine and tissue-bound or soluble benzylamine oxidases, could behave as a potassium channel blocking agent. Potassium channel blockers are known to modify several forms of animal behaviour including food consumption. To characterise further the pharmacological profile of benzylamine and the role of amine oxidases, we have studied the effect of benzylamine on mice food intake. Our results confirm that benzylamine produces a reduction in mice feeding in a similar manner to that obtained by amphetamine. The anorectic effect of benzylamine and amphetamine in mice was potentiated by pretreatment with amine oxidase inhibitors. In addition, the introduction of substituents in the aromatic ring of benzylamine did not produce compounds with a higher anorectic potency than the one measured with benzylamine.
RESUMEN
1. In starved mice, the anorectic activity of methylamine (MET) and benzylamine (BZ), both substrates of semicarbazide-sensitive benzylamine oxidases (Bz-SSAO), was compared with that of the potassium channel blocking agents charybdotoxin (ChTX), tetraethylammonium (TEA), gliquidone (GLI), ammonium chloride (NH(4)(+)) and of the anoressants amphetamine (AMPH) and nicotine (NIC). After i.c.v. administration, an approximate ranking order of potency was: ChTX> or =AMPH>NIC=TEA> or =GLI> or =MET>BZ>NH(4)(+). 2. Clorgyline (2.5 mg kg(-1) i.p.) or deprenyl (10 mg kg(-1) i.p.) potentiated the anorectic effect of i.c.v.-administered BZ, NIC and AMPH. The effect of TEA was increased only by deprenyl, while MET, NH(4)(+), ChTX and GLI were not affected by either of the inhibitors. 3. The Bz-SSAO inhibitors alpha-aminoguanidine (50 mg kg(-1) i.p.), B24 (100 mg kg(-1) i.p.) and MDL 72274 (2.5 mg kg(-1) i.p.) potentiated the effect of i.p., but not of i.c.v.-administered MET. 4. Antisense oligodeoxyribonucleotides (aODN) to Kv1.1 potassium channels abolished the effect of BZ and TEA, but was ineffective in reducing the activity of MET and other compounds. 5. These results suggest that MET is endowed with peculiar hypophagic effects at dosage levels that are not able to affect gross behaviour in mice. The effect of MET, differently from BZ, seems unrelated to an increase in the central release of monoaminergic mediators, as well as to a Kv1.1 blocking activity. Through a reduction of the endogenous breakdown of MET, Bz-SSAO inhibitors enhance the central pharmacological activity of this amine.
Asunto(s)
Anorexia/inducido químicamente , Bencilaminas/farmacología , Metilaminas/farmacología , Canales de Potasio con Entrada de Voltaje , Compuestos Alílicos/farmacología , Cloruro de Amonio/farmacología , Anfetamina/farmacología , Animales , Anorexia/patología , Conducta Animal/efectos de los fármacos , Bencilamino Oxidasa/antagonistas & inhibidores , Bencilamino Oxidasa/metabolismo , Caribdotoxina/farmacología , ADN sin Sentido/farmacología , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Guanidinas/farmacología , Inyecciones Intraventriculares , Canal de Potasio Kv.1.1 , Masculino , Ratones , Inhibidores de la Monoaminooxidasa/farmacología , Actividad Motora/efectos de los fármacos , Bloqueadores de los Canales de Potasio , Canales de Potasio/genética , Propilaminas/farmacología , Semicarbacidas/farmacología , Compuestos de Sulfonilurea/farmacología , Tetraetilamonio/farmacologíaRESUMEN
In mice deprived of food for 12 h, the i.c.v. or i.p. administration of benzylamine, a substrate common to both monoamine oxidase B and semicarbazide-sensitive benzylamine oxidases, dose-dependently inhibited feeding. This effect was significantly potentiated by selective monoamine oxidase A and B inhibition, suggesting that central monoamines, known to be substrates of these enzymes may be released. The i.p. administration of semicarbazide-sensitive benzylamine oxidase inhibitors, B24 (3,5-ethoxy-4-aminomethylpyridine) and MDL 72274 ((E)-2-phenyl-3-chloroallylamine) strongly potentiated the effect of i.p. but not i.c.v.-administered benzylamine. The hypophagic effect of benzylamine was evaluated following i.c.v. administration, in comparison with the effect of the sympathomimetic compound amphetamine or the K(+) channel blocker tetraethylammonium, as reference compounds. Our results make it possible to define benzylamine as a centrally acting hypophagic compound devoid of amphetamine-like motor stimulatory effects and point to a role of B24 and MDL 72274 as specific peripheral enhancers of the pharmacological effects of benzylamine.
Asunto(s)
Bencilaminas/farmacología , Conducta Alimentaria/efectos de los fármacos , Inhibidores de la Monoaminooxidasa/farmacología , Monoaminooxidasa/metabolismo , Compuestos Alílicos/farmacología , Anfetamina/farmacología , Animales , Clorgilina/farmacología , Dopaminérgicos/farmacología , Sinergismo Farmacológico , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Piperazinas/farmacología , Propilaminas/farmacología , Piridinas/farmacología , Selegilina/farmacología , Antagonistas de la Serotonina/farmacología , Especificidad por Sustrato , Tetraetilamonio/farmacologíaRESUMEN
Monoamine oxidase (MAO) and benzylamine oxidases (Bz-SSAO) of rat white adipocytes, deaminating benzylamine and tyramine produce hydrogen peroxide at different cellular levels. The peroxide produced by their activity has a very short half-life in adipocyte suspension. The addition of a catalase inhibitor allows for the recovery of the intact peroxide within the first 10-min of its production. Thus, benzylamine and tyramine-dependent peroxide recovery is different, suggesting that the fate of the peroxide produced by the two amine oxidases might be different depending on the cellular site of its production.
Asunto(s)
Adipocitos/enzimología , Bencilamino Oxidasa/metabolismo , Peróxido de Hidrógeno/metabolismo , Monoaminooxidasa/metabolismo , Tiramina/metabolismo , Animales , Masculino , Ratas , Ratas WistarRESUMEN
In traditional medicine the fresh leaves and juice of Sedum telephium L. are used as wound-healing promoters. Cell adhesion represents a primary event in wound repair and in tissue homeostasis, and therefore we have investigated the effect of Sedum juice and its main fractions, polysaccharides and flavonols, on human fibroblast (MRC5) adhesion to fibronectin and laminin. Our findings revealed that total Sedum juice strongly inhibited cell adhesion to laminin and fibronectin (EC50 1.03+/-0.12 mg mL(-1)). This anti-adhesive feature was concentrated mainly in the two polysaccharide fractions (EC50 values comprised between 0.09 and 0.44 mg mL(-1)). The flavonol fractions did not seem to contribute to this effect. A first attempt to elucidate the polysaccharide-related anti-adhesive feature of Sedum juice was also performed. The results confirmed that natural polysaccharides, with chemical structures different from heparin, were able to interfere with integrin-mediated cell behaviour and they contributed to the outstanding effects of Sedum juice and to the role of polysaccharides in cell-matrix interaction.
Asunto(s)
Fibroblastos/efectos de los fármacos , Fibronectinas/efectos de los fármacos , Laminina/efectos de los fármacos , Extractos Vegetales/farmacología , Polisacáridos/farmacología , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Línea Celular , Fibroblastos/fisiología , Fibronectinas/metabolismo , Flavonoides/farmacología , Flavonoles , Humanos , Laminina/metabolismo , Plantas MedicinalesRESUMEN
In rat, white adipocytes monoamine oxidases (EC 1.4.3.4.) generate hydrogen peroxide (H(2)O(2)). Recent studies suggested that, in addition to its toxic features, H(2)O(2) may behave as a cell second messenger. In the present study, using fluorimetric and chemiluminescence (CL) assays, we showed that tyramine degradation by monoamine oxidases in intact adipocytes resulted in the concentration-dependent generation of H(2)O(2). In addition, we found that, in the presence of low tyramine concentrations, forskolin-dependent cAMP production was significantly increased as compared to that of the control and this increase was prevented by the monoamine oxidase inhibitor pargyline or by the H(2)O(2) trapping system homovanillic acid-peroxidase. Finally, we demonstrated that tyramine degradation by monoamine oxidases increased the ability of isoproterenol to induce cell lipolysis. Taken together, these data suggest that H(2)O(2) produced during substrate degradation by monoamine oxidases may participate in the regulation of adipocyte metabolism.
Asunto(s)
Adipocitos/metabolismo , Peróxido de Hidrógeno/metabolismo , Monoaminooxidasa/metabolismo , Adipocitos/citología , Agonistas Adrenérgicos beta/farmacología , Animales , Radioisótopos de Carbono , Colforsina/farmacología , AMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Glicerol/metabolismo , Isoproterenol/farmacología , Masculino , Inhibidores de la Monoaminooxidasa/farmacología , Pargilina/farmacología , Ratas , Ratas Wistar , Semicarbacidas/farmacología , Tiramina/metabolismo , Tiramina/farmacologíaRESUMEN
PURPOSE: To explore the role of a natural polysaccharide extracted from tamarind seed (xyloglucan, or tamarind seed polysaccharide, TSP) on the integrin-substrate recognition system and on repair of corneal wounds. METHODS: a) Cultured human conjunctival cells were labeled by addition of a tritiated amino acid mixture. Their adhesion to laminin-coated culture wells in the absence or presence of TSP was checked by radioactivity count. b) The corneal epithelium of albino rabbits was damaged by applying a paper disc soaked with n-heptanol. The eyes were then treated with TSP, with a hyaluronate reference formulation and with normal saline solution (controls). The diameter of corneal wounds was measured daily, after fluorescein staining. RESULTS: Compared to hyaluronate, TSP slightly but significantly increased the wound healing rate. TSP 1.0% exerted a positive influence on cell adhesion to laminin, up to a certain laminin concentration. CONCLUSIONS: The ability of the polysaccharide to promote corneal wound healing might depend on its influence on the integrin recognition system.
Asunto(s)
Conjuntiva/metabolismo , Epitelio Corneal/efectos de los fármacos , Glucanos , Laminina/metabolismo , Polisacáridos/farmacología , Cicatrización de Heridas/efectos de los fármacos , Xilanos , Animales , Quemaduras Químicas/tratamiento farmacológico , Adhesión Celular/efectos de los fármacos , Células Cultivadas , Conjuntiva/citología , Epitelio Corneal/lesiones , Quemaduras Oculares/inducido químicamente , Heptanol , Humanos , Masculino , Soluciones Oftálmicas/farmacología , Plantas Medicinales , Conejos , SemillasRESUMEN
In stimulated rat vas deferens, the new compound 2, 6-dibutylbenzylamine (B25) and some related benzylamines, first potentiated then completely inhibited electrically-induced twitch response, showing the biphasic effect previously observed in unstimulated preparations. To verify if this effect could be referred to as a modulation of potassium channels the activity of some benzylamines, KCl, tetraetylammonium (TEA), BaCl(2), 4-aminopyridine (4-AP), glibenclamide (GLI), charibdotoxin (ChTX) and apamin (APA) has been compared. While KCl and benzylamine-related derivatives induced biphasic effects, TEA, 4-AP, BaCl(2), GLI stimulated but were unable to inhibit the twitches. The pretreatment with stimulating concentrations of TEA, 4-AP, GLI, APA or ChTX and B25, as reference compound in the benzylamine series, dose-dependently reduced the stimulatory effect of KCl but were unable to modify the inhibitory effect induced by this ion. Both KCl and B25 potentiated each others own inhibitory effect suggesting that, unlike other potassium channel blockers, they could modulate in an opposite way voltage-dependent potassium channels in order to facilitate and then depress neurotransmission. In other experiments, benzylamines, KCl, TEA, 4-AP and GLI reverted the inhibitory effect of cromakalim and omega-conotoxin GVIA (omega-CTX). This effect further supports a common mechanism of action (potassium channel blockade) probably inducing the opening of Ca(2+)channels different from N or L in the preparation. Finally, the prevention of minoxidil-induced amnesia in the mouse by B25 and related benzylamines, comparable to the same effect shown by TEA and 4-AP, indicates that these compounds are endowed with potential pharmacological activity in the CNS as well.
Asunto(s)
Bencilaminas/farmacología , Memoria/efectos de los fármacos , Bloqueadores de los Canales de Potasio , Transmisión Sináptica/efectos de los fármacos , Conducto Deferente/inervación , Animales , Reacción de Prevención/efectos de los fármacos , Bencilaminas/administración & dosificación , Bloqueadores de los Canales de Calcio/farmacología , Cromakalim/farmacología , Técnicas In Vitro , Inyecciones Intraventriculares , Masculino , Ratones , Contracción Muscular/efectos de los fármacos , Dimensión del Dolor/efectos de los fármacos , Equilibrio Postural/efectos de los fármacos , Ratas , Tiempo de Reacción/efectos de los fármacos , Estimulación Química , Conducto Deferente/efectos de los fármacos , omega-Conotoxinas/farmacologíaRESUMEN
Partial depolarisation of smooth muscle in endothelium-denuded rat aortic ring preparations, by increasing physiological buffer KC1 concentrations from 4.7 to 14.7 mM, produced a leftward shift of concentration response curves (CRCs) to the alpha 1-adrenoceptor agonist noradrenaline (NA), phenylephrine and methoxamine, without changing maximal responses, whereas maximal responses to clonidine (CLON), also an alpha 1-agonist in this tissue were considerably increased. Partial depolarisation did not alter responses to 10 nM NA or 100 nM CLON in Ca2+(-free) buffer, but significantly increased the contractions obtained on adding Ca2+ back in the presence of the agonists. The potentiation of NA (2.5 and 5 nm) contractions by partial depolarisation was prevented by the voltage-operated Ca2+ channel (VOCC) antagonist nifedipine (NIF, 1 microM). NIF did not significantly affect NA CRCs in 4.7 mM KCl, whereas responses in 14.7 mM KCl were significantly decreased, indicating VOCC recruitment by NA only in the latter condition. Initial depletion of intracellular Ca2+ stores with 1 microM thapsigargin (THAP) in Ca2+(-free) buffer did not alter NA CRCs subsequently obtained in normal Ca2+. However, after THAP-pretreatment, these NA responses (in both 4.7 and 14.7 mM KC1) were attenuated by NIF, indicating that VOCCs were activated by NA in THAP-treated tissues. SKF 96365 (SKF, 30 microM), which can block VOCC and non-VOCC routes of extracellular Ca2+ influx, inhibited NA responses in 4.7 mM and 14.7 mM KCl, possibly implying a role for both types of Ca2+ entry in contractions. However, the greater inhibitory effects of SKF in THAP-pretreated tissues, probably reflected the mobilisation of VOCCs by NA following THAP exposure, because SKF was shown separately to block VOCC-mediated contractions in tissues depolarised with 100 mM KCl alone. 10 microM niflumic acid, an inhibitor of Ca2+(-activated) Cl- channels, did not affect responses to NA in 4.7 mM or 14.7 mM KC1, suggesting that VOCC opening induced by NA in 14.7 mM KCl was not due to depolarisation produced by alpha 1-adrenoceptor induced Cl- efflux. CRCs for NA were unaffected by pretreatment of rings with 100 ng ml-1 pertussis toxin (PT), suggesting a lack of involvement of PT-sensitive G proteins in the contractions obtained either in 4.7 or 14.7 mM KCl. BMY 7378 (100 microM), a selective antagonist for alpha 1D-adrenoceptors, competitively inhibited NA contractions with apparent pKB values of 8.7 +/- 0.2 and 8.4 +/- 0.1 in 4.7 mM and 14.7 mM KCl, respectively. Pretreatment of rings with chloroethylclonidine (100 microM), an irreversible antagonist of alpha 1B-and alpha 1D-adrenoceptors, produced similar rightward shifts in CRCs to NA by 3.2 +/- 0.2 and 3.7 +/- 0.3 log concentration units in 4.7 mM and 14.7 mM KCl, respectively, without changing maximal responses. Inositol phosphate (IP) turnover produced by NA in aortic rings was not significantly different in 4.7 mM compared with 14.7 mM KCl. As a whole, these results suggest that partial depolarisation of the rat aorta with KCl enhances alpha 1-adrenoceptor mediated contractions predominantly via the alpha 1D-subtype, and by a mechanism to be identified which allows greater recruitment of VOCCs by NA. In addition, the ability of THAP-pretreatment also to enhance VOCC activation by NA suggests that Ca2+ release from, or prevention of its reuptake into, intracellular stores may contribute to those processes leading to VOCC opening.
Asunto(s)
Agonistas alfa-Adrenérgicos/farmacología , Aorta/efectos de los fármacos , Calcio/fisiología , Norepinefrina/farmacología , Cloruro de Potasio/farmacología , Receptores Adrenérgicos alfa 1/fisiología , Animales , Aorta/fisiología , Bloqueadores de los Canales de Calcio/farmacología , Técnicas In Vitro , Fosfatos de Inositol/biosíntesis , Masculino , Nifedipino/farmacología , Ratas , Ratas Sprague-Dawley , Receptores Adrenérgicos alfa 1/efectos de los fármacos , Vasoconstricción/fisiologíaRESUMEN
In rat white adipocytes histamine is oxidized by a semicarbazide-sensitive amine oxidase which has benzylamine or preferential substrate (Bz-SSAO). To determine whether Bz-SSAO could control the extracellular levels of histamine and other histamine-related compounds active in lipid mobilization, a series of histaminergic compounds was screened as possible substrates or inhibitors of Bz-SSAO activity. Histaminergic compounds with imidazolo or thiazolo groups are oxidized by rat white-adipocyte Bz-SSAO whereas S-isothiourea derivatives, with two- or three-carbon-atom alkyl chains between the isothiourea and the N,N-dimethyl residue are, instead, inhibitors of the enzyme. Amtamine has been identified as a selective, high affinity substrate for rat white adipocyte Bz-SSAO. This enzymatic degradation might represent a catabolic pathway for the drug. These results show that the histaminase property of the rat white-adipocyte enzyme Bz-SSAO also extends to other histamine derivatives active at histamine receptors.
Asunto(s)
Adipocitos/efectos de los fármacos , Adipocitos/enzimología , Amina Oxidasa (conteniendo Cobre)/metabolismo , Bencilaminas/metabolismo , Histamina/análogos & derivados , Monoaminooxidasa/metabolismo , Adipocitos/metabolismo , Amina Oxidasa (conteniendo Cobre)/antagonistas & inhibidores , Animales , Células Cultivadas , Diálisis , Histamina/metabolismo , Masculino , Inhibidores de la Monoaminooxidasa/farmacología , Oxidación-Reducción , Ratas , Ratas Wistar , Relación Estructura-Actividad , Tiourea/análogos & derivados , Tiourea/farmacologíaRESUMEN
OBJECTIVE AND DESIGN: Investigate the reaction conditions which allow the measurement of high affinity histamine oxidation. MATERIAL: Isolated rat white adipocytes. METHODS: The histaminase activity of rat white adipocytes and its inhibition by B24 and MDL 72274 was measured fluorimetrically or radiochemically in different experimental conditions. RESULTS: Histamine oxidation by rat white adipocytes is enhanced by elevated pH and by the presence of bicarbonate ions. Under these conditions the oxidative deamination of histamine by white adipocytes, becomes comparable to that of other histaminases, suggesting that this amine oxidase activity may play a role in the catabolism of histamine in vivo. The specific semicarbazide-sensitive amine oxidase (SSAO) inhibitors MDL 72274 and B24 inhibit the oxidation of both histamine and benzylamine by the adipocyte preparation. CONCLUSIONS: Although there are kinetic differences between the behaviour of these two amine substrates, these results would be consistent with a SSAO being responsible for both activities.
Asunto(s)
Adipocitos/enzimología , Amina Oxidasa (conteniendo Cobre)/metabolismo , Histamina/química , Adipocitos/citología , Adipocitos/efectos de los fármacos , Compuestos Alílicos/farmacología , Amina Oxidasa (conteniendo Cobre)/antagonistas & inhibidores , Animales , Benzaldehídos/metabolismo , Bencilaminas/química , Bencilaminas/metabolismo , Bicarbonatos/química , Bicarbonatos/farmacología , Radioisótopos de Carbono , Separación Celular , Inhibidores Enzimáticos/farmacología , Histamina/metabolismo , Concentración de Iones de Hidrógeno , Marcaje Isotópico , Masculino , Octoxinol/química , Oxidación-Reducción , Propilaminas/farmacología , Piridinas/farmacología , Ratas , Ratas WistarRESUMEN
The vasodilatatory, endothelium-mediated, effect of histamine (H), through H1 receptor, in the isolated and perfused mesenteric bed of the rat, undergoes strong desensitization during perfusion or repetitive injections of noradrenaline (NA) and H. The mesenteric bed completely desensitized to H is responsive to carbachol (C) and this latter compound does not affect the H desensitization. The homologous desensitization to C effect is very small, attaining less than 10% after 30 min of continuous perfusion. In this work the effect of inhibitors or activators of protein-kinase(s)-C (PKC) are studied during continuous perfusion of H or C in preparations preconstricted by NA. Staurosporine antagonizes the onset of the H desensitization, while the rate of desensitization in increased by phorbol-12-myristate-13-acetate (PMA). PMA, at a concentration from 10(-12) to 10(-10)M, selectively enhances the homologous desensitization of H, while at 10(-8)M it also produces a desensitization to C. At least two different PKC isoenzymes might be involved in the desensitization of the vasodilatatory effect of H and C in the isolated and perfused rat mesenteric bed.
Asunto(s)
Histamina/farmacología , Arterias Mesentéricas/efectos de los fármacos , Proteína Quinasa C/metabolismo , Receptores Histamínicos H1/efectos de los fármacos , Acetato de Tetradecanoilforbol/toxicidad , Vasodilatación/efectos de los fármacos , Envejecimiento/metabolismo , Alcaloides/farmacología , Animales , Carbacol/farmacología , Relación Dosis-Respuesta a Droga , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Activación Enzimática/efectos de los fármacos , Inhibidores Enzimáticos/administración & dosificación , Inhibidores Enzimáticos/farmacología , Histamina/administración & dosificación , Masculino , Arterias Mesentéricas/metabolismo , Norepinefrina/administración & dosificación , Norepinefrina/farmacología , Parasimpaticomiméticos/farmacología , Perfusión , Proteína Quinasa C/antagonistas & inhibidores , Ratas , Ratas Wistar , Receptores Histamínicos H1/metabolismo , Estaurosporina , Vasoconstrictores/administración & dosificación , Vasoconstrictores/farmacologíaRESUMEN
We have investigated whether the effects in white adipose tissue due to insulin deficiency might also be related to an alteration of histamine levels which are regulated by semicarbazide-sensitive amine oxidase. The lack of circulating insulin induced by streptozotocin produced, in rat white adipose tissue, a loss of affinity of the semicarbazide-sensitive amine oxidase for histamine oxidation. In parallel, a decrease of cell transformation, measured by glycerol-3-phosphate dehydrogenase activity and an augmented sensitivity to histamine lipolysis were observed. These findings could contribute to the understanding of histamine metabolism and function in diabetic rats and to the knowledge concerning amine oxidases in this animal pathology.
Asunto(s)
Tejido Adiposo/enzimología , Amina Oxidasa (conteniendo Cobre)/metabolismo , Diabetes Mellitus Experimental/enzimología , Animales , Glucemia/metabolismo , Peso Corporal/fisiología , Glutamato Deshidrogenasa/metabolismo , Histamina/metabolismo , Cinética , Lipólisis/efectos de los fármacos , Masculino , Tamaño de los Órganos/fisiología , Ratas , Ratas WistarRESUMEN
In the mesenteric arterial bed of the rat the semicarbazide-sensitive amine oxidase with a high affinity for benzylamine (Bz. SSAO) (E.C. 1.4.3.6) is also able to oxidize histamine. In the perfused mesenteric arterial bed of the rat the complete inhibition of the Bz. SSAO obtained with a specific inhibitor, B24, almost completely reduces the efflux of imidazole acetic acid and increases the relaxing effect of histamine. Bz. SSAO appears to be the only enzyme present in these blood vessels able to catabolize histamine.
Asunto(s)
Amina Oxidasa (conteniendo Cobre)/metabolismo , Histamina/metabolismo , Arterias Mesentéricas/enzimología , Amina Oxidasa (conteniendo Cobre)/antagonistas & inhibidores , Animales , GMP Cíclico/metabolismo , Histamina/farmacología , Imidazoles/metabolismo , Técnicas In Vitro , Masculino , Proteínas/metabolismo , Ratas , Ratas Wistar , Taquifilaxis/fisiología , Vasodilatación/efectos de los fármacosRESUMEN
A semicarbazide-sensitive amine oxidase activity with a high affinity for benzylamine (Bz.SSAO) (E.C. 1.4.3.6) is present in guinea pig dorsal skin. This enzymic activity oxidized benzylamine, histamine, 1,4-methylhistamine and acetylputrescine and was inhibited by semicarbazide and by B24 (3,5-diethoxy-4-aminomethylpyridine), a selective inhibitor of Bz.SSAO enzymes. It cross reacted with the antibodies raised against pure pig plasma benzylamine oxidase. Immunohistochemistry showed that it was localized in fibroblasts. Bz.SSAO activity of guinea pig dorsal skin increased during the process of skin healing. A treatment of the wounds with 3 micrograms of b-FGF significantly accelerated the process of skin healing and the increase of Bz.SSAO activity.
Asunto(s)
Amina Oxidasa (conteniendo Cobre) , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/metabolismo , Piridinas/farmacología , Semicarbacidas/farmacología , Piel/enzimología , Animales , Factor 2 de Crecimiento de Fibroblastos/farmacología , Cobayas , Inmunohistoquímica , Masculino , Peso Molecular , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/antagonistas & inhibidores , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/aislamiento & purificación , Piel/lesiones , Especificidad por Sustrato , Cicatrización de HeridasRESUMEN
In rat mesenteric artery homogenates histamine is oxidatively deaminated at high rate whereas putrescine is a poor substrate. The oxidation of histamine appears to be mainly catalyzed by an SSAO enzyme with high affinity for benzylamine (Bz.SSAO). Histamine oxidation is inhibited by B24 (2,5-diethoxy-4-aminomethylpyridine), a selective inhibitor of Bz.SSAO enzymes, and reduced by the presence of benzylamine. The Bz.SSAO enzyme which is present in the rat mesenteric artery is not only able to oxidize histamine, but also methylamine, acetylputrescine and some methylated forms of histamine including 1,4-methylhistamine.
Asunto(s)
Amina Oxidasa (conteniendo Cobre)/metabolismo , Arterias Mesentéricas/enzimología , Aminas/metabolismo , Animales , Bencilaminas/metabolismo , Unión Competitiva , Desaminación , Histamina/metabolismo , Cinética , Masculino , Oxidación-Reducción , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/metabolismo , Putrescina/metabolismo , Ratas , Ratas Wistar , Semicarbacidas/farmacologíaRESUMEN
Histamine has previously been described as a possible substrate for the semicarbazide-sensitive amine oxidase activity (SSAO) of rat white adipose tissue (WAT). We report here on a histamine function in this tissue which concerns the activity of this deaminating system distinct from the classical diamine oxidase. Our results show that: (1) histamine plays a role in controlling rat adipose tissue lipolysis with the contribution of H1 and H2 receptors that participate in histamine lipolysis in an opposite way. Both H1 and H2 roles can be differentiated using selective agonists (2- and 4-methyl histamine) and antagonists (pyrilamine and cimetidine); (2) histamine might also control rat lipolysis induced by noradrenergic agonists; (3) the SSAO present in rat WAT controls histamine levels at the receptor sites as shown by the modification of histamine lipolytic potency obtained when inhibitors of this enzyme are used.